Forecast of new brand and LOE impact in developed pharma markets 2019-2026

Published by
Matej Mikulic,
Mar 27, 2023
This statistic shows the forecast of new brand and brand loss of exclusivity (LOE) impact in developed pharma markets from 2019 to 2026, in billion U.S. dollars. According to the forecast, in 2022, the loss of exclusivity is expected to have a negative impact of some 32 billion U.S. dollars while the new brand spending would be a gain of 31 billion U.S. dollars.

Forecast of new brand and brand loss of exclusivity (LOE) impact in developed pharmaceutical markets from 2019 to 2026 (in billion U.S. dollars)

© Statista 2024
Download
Show detailed source information?
Register for free
Already a member?
Log in
Source

Use Ask Statista Research Service

Release date

December 2021

Region

Worldwide

Survey time period

as of November 2021

Supplementary notes

Developed markets include: U.S., Japan, Germany, France, Italy, U.K., Spain, Canada, S.Korea, Australia; LOE = loss of exclusivity.
All values are rounded estimates/forecasts and in constant U.S. dollars.

Citation formats
Access all statistics starting from $2,388 USD yearly *

* For commercial use only

Basic Account

For single users
$0 USD
Always free
Access limited to Free Statistics. Premium Statistics are not included.
  • Free Statistics
Based on your interests

Starter Account

For single users
$199 USD
per month, billed annually 1
Buy now
  • Free Statistics
  • Premium Statistics

    • The statistic on this page is a Premium Statistic and is included in this account.

Professional Account

For teams of up to 5 people
$959 USD
per month, billed annually 1
Buy now
  • Free + Premium Statistics
  • Reports
  • Market Insights

1 All prices do not include sales tax. The account requires an annual contract and will renew after one year to the regular list price.

Compare accounts

Statistics on " Generics and biosimilars "

The most important statistics
The most important statistics
The most important statistics
The most important statistics
The most important statistics
The most important statistics

Other statistics that may interest you Generics and biosimilars

Global overview

4

Top companies

4

U.S. market

6

Patent expiration

6

Savings

7

Biosimilars

7

Further related statistics

17

Further Content: You might find this interesting as well

Statistics

Topics

Pharmaceutical market in the PhilippinesInsurance industry in the PhilippinesDemographics of the PhilippinesCoronavirus (COVID-19) pandemic in the PhilippinesHealthcare in the Philippines
Access all statistics starting from $2,388 USD yearly *

* For commercial use only

Basic Account

For single users
$0 USD
Always free
Access limited to Free Statistics. Premium Statistics are not included.
  • Free Statistics
Based on your interests

Starter Account

For single users
$199 USD
per month, billed annually 1
Buy now
  • Free Statistics
  • Premium Statistics

    • The statistic on this page is a Premium Statistic and is included in this account.

Professional Account

For teams of up to 5 people
$959 USD
per month, billed annually 1
Buy now
  • Free + Premium Statistics
  • Reports
  • Market Insights

1 All prices do not include sales tax. The account requires an annual contract and will renew after one year to the regular list price.

Compare accounts
Learn more about how Statista can support your business.